Massimo Roncalli

17.4k total citations · 1 hit paper
228 papers, 11.5k citations indexed

About

Massimo Roncalli is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Massimo Roncalli has authored 228 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 63 papers in Epidemiology and 57 papers in Hepatology. Recurrent topics in Massimo Roncalli's work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (43 papers) and Lung Cancer Treatments and Mutations (24 papers). Massimo Roncalli is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (43 papers) and Lung Cancer Treatments and Mutations (24 papers). Massimo Roncalli collaborates with scholars based in Italy, United States and Switzerland. Massimo Roncalli's co-authors include Luca Di Tommaso, Armando Santoro, Annarita Destro, Luigi Terracciano, Guido Coggi, Young Nyun Park, Marco Alloisio, Mauro Borzio, Paolo Bianchi and Alberto Malesci and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Massimo Roncalli

227 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

2009 455 citations Federico Cappuzzo, Antonio Marchetti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Roncalli Italy	59	4.7k	3.3k	3.2k	2.7k	2.1k	228	11.5k
Tim Meyer United Kingdom	55	4.9k 1.0×	2.2k 0.7×	2.6k 0.8×	6.7k 2.5×	4.2k 2.0×	237	13.8k
Hui‐Chuan Sun China	58	3.1k 0.7×	1.6k 0.5×	5.0k 1.6×	3.7k 1.4×	2.0k 0.9×	308	11.8k
Gabriella Fontanini Italy	56	7.2k 1.5×	4.7k 1.4×	5.3k 1.6×	1.1k 0.4×	955 0.5×	320	13.4k
Zhao–You Tang China	63	4.1k 0.9×	1.4k 0.4×	6.5k 2.0×	5.2k 2.0×	2.8k 1.3×	209	14.8k
Anton J. Bilchik United States	50	5.3k 1.1×	1.6k 0.5×	1.4k 0.4×	1.6k 0.6×	1.2k 0.6×	200	8.8k
Ronnie T. P. Poon Hong Kong	54	3.5k 0.7×	1.7k 0.5×	3.0k 0.9×	4.5k 1.7×	2.3k 1.1×	137	10.2k
Toshiro Niki Japan	55	5.3k 1.1×	4.5k 1.4×	6.1k 1.9×	991 0.4×	1.4k 0.6×	234	14.4k
Jeffrey A. Drebin United States	47	6.6k 1.4×	2.3k 0.7×	3.2k 1.0×	791 0.3×	1.0k 0.5×	211	11.1k
Michiie Sakamoto Japan	79	5.5k 1.2×	2.8k 0.8×	6.5k 2.0×	8.0k 3.0×	5.6k 2.7×	406	20.4k
Huamin Wang United States	74	11.5k 2.4×	4.0k 1.2×	5.6k 1.7×	1.1k 0.4×	2.7k 1.3×	256	17.9k

Countries citing papers authored by Massimo Roncalli

Since Specialization

Citations

This map shows the geographic impact of Massimo Roncalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Roncalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Roncalli more than expected).

Fields of papers citing papers by Massimo Roncalli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Roncalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Roncalli. The network helps show where Massimo Roncalli may publish in the future.

Co-authorship network of co-authors of Massimo Roncalli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Roncalli. A scholar is included among the top collaborators of Massimo Roncalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Roncalli. Massimo Roncalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cortese, Nina, Matteo Donadon, Marco Di Maio, et al.. (2021). Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis. Cancers. 13(13). 3313–3313. 7 indexed citations

Personeni, Nicola, Tiziana Pressiani, Antonio D’Alessio, et al.. (2021). Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers. 13(22). 5665–5665. 11 indexed citations

Donadon, Matteo, Guido Torzilli, Nina Cortese, et al.. (2020). Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis. The Journal of Experimental Medicine. 217(11). 110 indexed citations

Roncalli, Massimo, et al.. (2020). How Are We Facing It? Dispatches From Pathology Residents in a COVID-19 Lombardy Hospital. Frontiers in Public Health. 8. 259–259. 4 indexed citations

Personeni, Nicola, Marina Baretti, Silvia Bozzarelli, et al.. (2016). Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications. Gastric Cancer. 20(3). 428–437. 4 indexed citations

Roncalli, Massimo, et al.. (2016). Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma. Modern Pathology. 29(3). 283–292. 43 indexed citations

Ghidini, Michele, Francesco Trevisani, Matteo Fassan, et al.. (2015). Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs). Annals of Oncology. 26. vi96–vi96. 1 indexed citations

Celesti, Giuseppe, G.Q. Di, Paolo Bianchi, et al.. (2013). Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis. British Journal of Cancer. 109(9). 2424–2433. 23 indexed citations

Davies, Kurtis D., Anh T. Le, Mariana F. Theodoro, et al.. (2012). Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(17). 4570–4579. 330 indexed citations

10.

Cappuzzo, Federico, Yong Gon Cho, Andrea Sacconi, et al.. (2012). p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 7(3). 520–527. 15 indexed citations

11.

Romagnoli, Solange, Ester Fasoli, Valentina Vaira, et al.. (2009). Identification of Potential Therapeutic Targets in Malignant Mesothelioma Using Cell-Cycle Gene Expression Analysis. American Journal Of Pathology. 174(3). 762–770. 40 indexed citations

12.

Leidi, Marzia, Elisa Gotti, Luca Bologna, et al.. (2009). M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro. The Journal of Immunology. 182(7). 4415–4422. 220 indexed citations

13.

Infante, Maurizio, Silvio Cavuto, Romano Fabio Lutman, et al.. (2009). A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. American Journal of Respiratory and Critical Care Medicine. 180(5). 445–453. 273 indexed citations

14.

Baryshnikova, Ekaterina, Annarita Destro, Maurizio Infante, et al.. (2008). Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening Program. Clinical Cancer Research. 14(6). 1913–1919. 47 indexed citations

15.

Marchesi, Federica, Lorenzo Piemonti, Giuseppe Fedele, et al.. (2008). The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma. Cancer Research. 68(21). 9060–9069. 142 indexed citations

16.

Santoro, Alessandra, Raffaele Cavina, F Latteri, et al.. (2003). Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer. Annals of Oncology. 15(1). 33–37. 32 indexed citations

17.

Balzarotti, Monica, Michele Spina, Barbara Sarina, et al.. (2002). Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Annals of Oncology. 13(9). 1341–1346. 23 indexed citations

18.

Theise, Neil D., Young Nyun Park, Swan N. Thung, Massimo Roncalli, & Mauro Borzio. (2000). 'Vascular profiles' of regenerative and dysplastic nodules [3] (multiple letters). Hepatology. 31(6). 1380–1381. 1 indexed citations

19.

Borzio, Mauro, Savino Bruno, Massimo Roncalli, et al.. (1995). Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study. Gastroenterology. 108(3). 812–817. 159 indexed citations

20.

Roncalli, Massimo, et al.. (1988). Immunophenotypic analysis of the transformation zone of human cervix.. PubMed. 58(2). 141–9. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact